BiotechTube
Home/Vivos Therapeutics/Kirk Huntsman
KH

Kirk Huntsman

Chief Executive Officer

Vivos Therapeutics

Therapeutic Areas

Obstructive Sleep ApneaSleep-Disordered Breathing

Vivos Therapeutics Pipeline

DrugIndicationPhase
Vivos CARE Appliances (DNA, mRNA, mmRNA)Mild-to-Severe Obstructive Sleep Apnea (Adults)Commercial
DNA Appliance (Pediatric)Moderate-to-Severe Obstructive Sleep Apnea (Children 6-17)Commercial